NASDAQ:JAGX
Jaguar Health stock swings as Future Pak licensing deal dangles $38 million — here’s what traders see
Jaguar Health, Inc shares dropped roughly 9% Monday after announcing a U.S. licensing deal with an affiliate of private company Future Pak, potentially generating up to $38 million for its crofelemer products. The stock…
Company hubNASDAQ:JAGX
Jaguar Health (JAGX) Stock News & Analysis
Follow the latest Jaguar Health (JAGX) company news, earnings coverage and investor analysis from TechStock².
Save this hub to your TS2 Signalbook account.
- Latest update
- Articles in this hub
- 1
- Last 30 days
- 0
What investors are watching
- Earnings, guidance and financial performance
- Valuation, trading activity and market sentiment
- Strategy, catalysts and company-specific risks
All coverage
